# Long-term Extension Trial of Asenapine in Subjects With Schizophrenia (Study P06125)

> **NCT01142596** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 201 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Asenapine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01142596
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05-25
- **Primary completion:** 2015-04-22
- **Final completion:** 2015-04-22
- **Target enrollment:** 201 (ACTUAL)
- **Last updated:** 2024-05-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01142596

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01142596, "Long-term Extension Trial of Asenapine in Subjects With Schizophrenia (Study P06125)". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01142596. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*